| Pan, Hongxing |
NCT05079217: Safety and Immunogenicity Study of Booster Vaccination With Medium-dosage or High-dosage SARS-CoV-2 Inactivated Vaccine for Prevention of COVID-19 |
|
|
| Active, not recruiting | 4 | 1200 | RoW | High-dosage SARS-CoV-2 vaccine, CoronaVac, Medium-dosage SARS-CoV-2 vaccine | Sinovac Biotech Co., Ltd | COVID-19 | 12/21 | 06/22 | | |
NCT05161845: Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live |
|
|
| Completed | 4 | 1068 | RoW | Measles, Mumps and Rubella Combined Vaccine, Live | Shanghai Institute Of Biological Products | Immunotoxicity, Vaccine | 04/22 | 10/22 | | |
NCT05137418: Safety and Immunogenicity of COVID-19 Vaccine, Inactivated in Healthy Population Aged From 3 to 11 Years |
|
|
| Completed | 3 | 1000 | RoW | COVID-19 Vaccine,Inactivated, CoronaVac | Sinovac Research and Development Co., Ltd. | COVID-19 | 01/23 | 01/23 | | |
NCT05381350: Immunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Variant) in Healthy People Aged 18 Years and Above |
|
|
| Completed | 3 | 1750 | RoW | COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant), COVID-19 Vaccine (Vero cell), Inactivated (CZ strain), CoronaVac | Sinovac Research and Development Co., Ltd. | COVID-19 | 09/22 | 03/23 | | |
NCT05839301: A Trial to Evaluate the Lot-to-lot Consistency of Live Attenuated Varicella Vaccine in Healthy People 1-12 Years of Age |
|
|
| Active, not recruiting | 3 | 1200 | RoW | Investigational live attenuated varicella vaccine (lot 1), Investigational live attenuated varicella vaccine (lot 2), Investigational live attenuated varicella vaccine (lot 3) | China National Biotec Group Company Limited, Beijing Institute of Biological Products Co Ltd., Jiangsu Province Center for Disease Control and Prevention | Varicella | 07/23 | 04/24 | | |
NCT05245552: A Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months |
|
|
| Completed | 3 | 217 | RoW | Quadrivalent influenza vaccine(0.25ml), Quadrivalent influenza vaccine(0.5ml), Trivalent influenza vaccine(BV), Trivalent influenza vaccine(BY) | Sinovac Biotech Co., Ltd | Seasonal Influenza | 08/23 | 08/23 | | |
NCT05669625: A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine |
|
|
| Active, not recruiting | 3 | 12440 | RoW | Investigational live attenuated varicella vaccine, Placebo of live attenuated varicella vaccine | China National Biotec Group Company Limited, Beijing Institute of Biological Products Co Ltd., Jiangsu Province Center for Disease Control and Prevention | Varicella | 04/24 | 09/26 | | |
| Sun, Guang wei |
| No trials found |
